Human Experimentation Summary

William A. Silverman’s Human Experimentation: A Guided Step into the Unknown, he encourages that we can do human experiments as long as it is a careful experimentation. He mentioned that randomized clinical trials that shows careful experimentation leads to effective therapy and a clearer understanding of clinical anomalies. With that being said, aside from effective therapies, clinical anomalies can be understood better through careful experimentation of randomized clinical studies, clinical anomalies can therefore be prevented (Silverman, 1985). Silverman has mentioned that human experimentation must be careful. He defined ‘being careful’ as being always reminded the codes and the laws that surrounds the field of experimentation using humans

Reviewing history, the Nuremberg code is a situated of exploration moral standards for human experimentation as a consequence of the Subsequent Nuremberg Trials approaching the end of the Second World War. Also, it was also described by Silverman that ‘careful experimentation’ is a type of experimentation that the physicians or researchers must have a full background on the field that is being targeted by the study that needs that kind of experimentation since ‘careful experimentation’ aims to prevent, and better, to eliminate clinical anomalies and accidents that typically happen during the treatment of the

The Food and Drug Administration (FDA) of United States imposed regulations as they adopted authorizing use of investigational new drugs that had no response to approved therapies. However, the FDA have not yet fully adopted it (approved medical devices), since it only constitutes non-validated practice. It is more on a form of practice than research (Enderle & Bronzino, 2012). The FDA have imposed some restrictions to that kind of experimentation since it follows, again, the Nuremberg code, specifically it follows the fourth point of the code where it should avoid any physical and mental suffering and injuries. Also, it was stated by Ederle and Bronzino that the FDA has not yet fully adopted the authorization of investigational new drugs (which means that these drugs are not yet approved as therapeutic drugs that aims to cure any diseases or illness) since the code dictates that it should only aim at positive results for the community and it must not be obtained in any other way. The Food and Drugs Administration has patterned its regulations for human experimentation in a way, that it will not violate any ethical declaration and any laws that are being enacted. It is significant that this kind of experimentation follows the current codes and laws that are nationally and internationally implemented to